Q² Solutions Announces Significant Expansion of Laboratory Operations in Scotland, UK
The expansion includes investments in facilities enhancements and new technologies that will strengthen capabilities and services offered to clients, including:
- Next-generation genetic sequencing capabilities, allowing the identification and analysis of genomic biomarkers that are becoming increasingly important in the understanding of disease and the development of new therapies and drugs.
- Cutting-edge flow cytometry technologies that allow the rapid measurement and analysis of cell populations than previously available to support clinical trials globally. This enables Q2 Solutions to greatly enhance its capability to provide useful, unique, and highly complex data to clients.
- Creation of a dedicated clean room for peripheral blood mononuclear cell (PBMC) isolation, used in a wide range of research and clinical areas such as HIV research and cancer immunotherapy.
“Expanding our capabilities at the Alba Campus reaffirms our commitment, within an ever-changing global regulatory landscape, to providing integrated laboratory services to regional and global biopharmaceutical companies,” said
Q2 Solutions is currently the largest life science employer in
About Q2 Solutions
Q2 Solutions is a leading global clinical trial laboratory services organization providing comprehensive testing, project management, supply chain, biorepository, biospecimen and consent tracking solutions. Leveraging our next generation technologies, we deliver agile and precise services designed to meet the diverse needs of our clients. We provide scientific expertise and innovative solutions for ADME, bioanalytical, genomics, vaccines and central laboratory services, including flow cytometry, anatomic pathology, immunoassay, molecular and companion diagnostics, with meticulous regional and global clinical trial implementation support and high-quality data delivery. At Q2 Solutions, our work is rooted in research, grounded in collaboration, and guided by our passion to turn the hope of patients and caregivers around the world into the help they need. To learn more, visit www.q2labsolutions.com.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, to advance their path toward cures. To learn more, visit www.iqvia.com.